483
James Whitlock, M.D.James Whitlock, M.D. – FDA 483, Apr 6, 2023
Record Details
An FDA inspection of James Whitlock, M.D., a clinical investigator in Toronto, revealed failures to conduct investigations in accordance with the investigational plan. Specifically, the firm was cited for under-reporting and late reporting of serious adverse events for subjects enrolled in a sponsored clinical protocol. These issues included misclassifying a grade 3 pancreatitis as grade 2 and submitting an expedited adverse event report beyond the protocol's allotted timeframe.
- Person
View Company Profile
ID · 73c2a6cc-bd7a-49e4-bdc5-d29edcb50920
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.